Drug Delivery & Formulations
Category VIEW ALL
Selective inhibitors of vancomycin-resistant enterococcus
Technology No. 2026-FLAH-71325
Solid particles of RNA lipid nanoparticles
Technology No. 2025-ZHOU-71178
Protein solids
Technology No. 2025-ZHOU-71177
Flexible Non-cationic Nanocapsules for Nucleic Acid Delivery
Technology No. 2020-YEO-68868
Tannic Acid-based Nanocapsules for Sustained Delivery of Immunogenic Cell Death Inducers
Technology No. 2020-YEO-68760
Macrotumor Engineering
Technology No. 2019-LELI-68697
Bilirubin-Coated Radio-Luminescent Particles, and Their Use for Radiation-Induced Photodynamic Therapy
Technology No. 2019-WON-68496
Liposome Formulation with High Drug Capacity
Technology No. 2019-YEO-68485
Rapid Purification of Biopharmaceuticals by Crystallization
Technology No. 2019-NAGY-68435
Phosphate Esters of Human Calcitonin
Technology No. 2019-TOPP-68428
Unnatural Proline-rich Antimicrobial Peptides Targeting Intracellular Pathogenic Bacteria and Antibiotic Conjugates Thereof
Technology No. 2019-CHMI-68405
Nanoparticles for Sepsis Treatment
Technology No. 2019-YEO-68355
Novel Inhalation Formulations of Colistin and Meropenem
Technology No. 2018-ZHOU-68233
Live Cell Conjugation Chemistry for Imaging, Sensing and Cell Therapy
Technology No. 2018-CHOP-68209
Liposomal Formulation of Combinational Antibiotics
Technology No. 2018-ZHOU-68205
Targeted Antimicrobial Photodynamic Therapy using GaPpIX Conjugates
Technology No. 2018-WEI-68200
Combination Pharmaceutical Formulations
Technology No. 2018-ZHOU-68184
Cleavable Conjugates of Antibiotics and an Antibacterial Cell-Penetrating Peptide
Technology No. 2018-CHMI-68009
Quinic Acid-Modified Nanoparticles
Technology No. 2017-YEO-67767
Albumin-coated Nanocrystals
Technology No. 2016-YEO-67581
Pyrimidinephenylthiazoles as Antimicrobials
Technology No. 2016-CUSH-67515
Preparation and Applications of Polyrotaxanes Bearing Mixed Cyclodextrin Species
Technology No. 2015-THOM-67198
Phosphate Ester Derivatives of Glucagon
Technology No. 2015-TOPP-67192
Radioluminescent Particles for Enhancement of Radiation Cancer Therapy
Technology No. 2015-WON-67028
A Chimeric EGF-Targeted Bacterial Toxin as Therapeutic Agent against Bladder Cancer
Technology No. 2014-AGUI-66886
Artificial, Multivalent Fibronectin-Binding Ligands for the Targeting of Bladder Tumor Cells
Technology No. 2014-AGUI-66861
Polymeric Cyclodextrin Carriers as NPC Therapeutics
Technology No. 2013-THOM-66383
Indenoisoquinoline Topoisomerase I Inhibitors Substituted with Carbohydrates
Technology No. 65707
Vaccine Linkers to Attach Proteins to Aluminum Hydroxide Adjuvants
Technology No. 65683
Affinity Stabilization of Protein Drugs
Technology No. 65558
2nd Generation FT Inhibitors
Technology No. 64935
Pharmaceutical Materials and methods for Their Preparation and Use
Technology No. 99050
Bacteriophage formulations
Technology No. 2025-ZHOU-70957
Gel forming polymers for improved oral peptide formulations
Technology No. 2025-TAYL-70925
5/5-5/6-BISARYL COMPOUNDS AS TRANSFORMING GROWTH FACTOR-β ACTIVATED KINASE, TAK1, INHIBITORS
Technology No. 2025-SINT-70883
Expressible HCV Nucleic Acid and Encoded Glycoprotein Antigens and Methods
Technology No. 2025-KUHN-71090
Engineered Polymeric Excipients for Enhancing the Stability of Protein Biologics
Technology No. 2024-WON-70668
A Sperm Glycoprotein-based Contraceptive Vaccine
Technology No. 2024-HOGE-70624
Analogs of Diphyllin
Technology No. 2024-DAVI-70723
Nanopuff: Albumin-coated siRNA-bound polydopamine nanoparticles
Technology No. 2023-YEO-70458
Combination of Phosphatidyl Serine Blockade and STING Stimulation for Cancer Immunotherapy
Technology No. 2023-YEO-70023
Excipient-Free Lyophilization of Aqueous Polymer Micelle Suspensions
Technology No. 2023-WON-69925
Precision 3D Printing Method for Customizable Pharmaceutical Mini-Tablets
Technology No. 2023-SUND-70094
Prodrugs of Nicotinamide N-Methyltransferase (NNMT) Inhibitors as Novel Therapeutic Agents
Technology No. 2023-HUAN-70285
A Novel Nanoparticle Adjuvant for Cancer Vaccines
Technology No. 2023-HOGE-70112
Bacterial Carbonic Anhydrase Inhibitors with Improved Pharmacokinetics and Efficacy
Technology No. 2023-FLAH-70278
Repurposing Phenol & Phosphate Anticancer Drugs as Cationic Lipid Salts in Solid Lipid Nanoparticles Focused on Etoposide
Technology No. 2023-BYRN-69951
Treatment of Lowe Syndrome
Technology No. 2023-AGUI-69998
Nanoparticle-based Abuse Deterrent Formulations
Technology No. 2022-YEO-69643
Immunoactive Nanocarrier of Immunogenic Cell Death Inducers
Technology No. 2022-YEO-69546
Sequence-Controlled Aliphatic Copolyesters
Technology No. 2022-WON-69547
Polymer Salts for Improved Drug Delivery from Amorphous Solid Dispersions
Technology No. 2022-TAYL-69671
Plasticizers to Improve Release Performance of Amorphous Solid Dispersions
Technology No. 2022-TAYL-69586
Nicotinamide-based Compounds as Potent Inhibitors of Translational- and Transcriptional-related Kinases
Technology No. 2022-SINT-69726
Cyanide Countermeasures
Technology No. 2022-DAVI-69921
Polymyxin Combinational Formulations
Technology No. 2021-ZHOU-69256
Single Crystal Matrix Isolation of Biopharmaceuticals for Enhanced Stability
Technology No. 2021-CHMI-69348
Novel inhalation formulations of polymyxins
Technology No. 2020-ZHOU-68990
Nano-composite Microparticles with Ivacaftor and Colistin
Technology No. 2020-ZHOU-68954
Griseofulvin Formulation for Therapy of Wet Macular Degeneration
Technology No. 2020-YEO-69132
Mixed Solvent Micelle Formulation Procedure
Technology No. 2020-WON-69093
